期刊文献+

血清miR-96、miR-182对肝细胞性肝癌的诊断价值及其比较分析 被引量:1

Diagnostic application and comparative analysis of serum miR-96 and miR-182 in patients with hepatocellular carcinoma
下载PDF
导出
摘要 目的:分析miRNA-96、miRNA-182在肝细胞性肝癌(hepatocellular carcinoma,HCC)诊断方面潜在的应用价值。方法:收集HCC、肝硬化(liver cirrhosis,LC)、慢性乙型肝炎(chronic hepatitis B,CHB)及正常对照血清各60例。以逆转录定量PCR方法检测miR-96、miR-182在血清中的相对表达量,以受试者工作曲线(receiver operating characteristic curve,ROC)分析两者在HCC诊断中的应用价值并与血清甲胎蛋白(alpha-fetoprotein,AFP)检测相比较。结果:HCC患者血清miR-96、miR-182相对表达量明显高于LC、CHB及正常对照组(FmiR-96=104.06,FmiR-182=318.23,均P<0.001),血清miR-96、miR-182 ROC下面积分别为0.901 5和0.936 8;miR-96对HCC诊断灵敏度和特异性分别为83.3%、80.8%,miR-182对HCC诊断灵敏度和特异性分别为85.0%、85.0%。两者诊断HCC灵敏度均优于血清AFP测定。结论:血清miR-96和miR-182是潜在的HCC诊断标志物。 Objective: To explore the diagnostic value of miRNA-96 and miRNA-182 in patients with hepatocellular carcinoma(HCC). Methods: Gene expression of miR-96 and miR-182 were examined in 60 serum samples from liver cirrhosis(LC),chronic hepatitis B(CHB) and health volunteers by quantitative real-time reverse transcription polymerase chain reaction(RTqPCR). The diagnostic efficiency of miR-96 and miR-182 on HCC were analyzed by receiver operating characteristic curve(ROC) and compared with alpha-fetoprotein(AFP). Results: Expression levels of miR-96 and miR-182 in HCC sera were significant higher than those in other groups(FmiR-96=104.06,FmiR-182=318.23, P〈0.001). The areas under ROC of miR-96 and miR-182 in sera were 0.901 5 and 0.936 8. MiR-96 had a sensitivity of 83.3% and a specificity of 80.8%, miR-182 had a sensitivity of 85.0% and a specificity of 85.0% in discriminating HCC from LC or CHB, respectively. The HCC diagnostic sensitivity of miR-96 and miR-182 were better than AFP in sera. Conclusion: The expression levels of miR-96 and miR-182 in sera may be considered potential novel biomarkers for the diagnosis of HCC.
出处 《南通大学学报(医学版)》 2014年第5期358-361,共4页 Journal of Nantong University(Medical sciences)
基金 南通市科技应用研究计划(K2010026) 国家国际科技合作专项(2013DFA32150)
关键词 肝细胞性肝癌 微小RNA 甲胎蛋白 hepatocellular carcinoma microRNA alpha-fetoprotein
  • 引文网络
  • 相关文献

参考文献12

  • 1Song P. Standardizing management of hepatocellular carci- noma in China: devising evidence-based clinical practice guidelines[J]. Biosci Trends, 2013, 7(5):250-252.
  • 2Soon P, Kiaris H. MicroRNAs in the tumour microenviron- ment: big role for small players[J]. Endocr Relat Cancer, 2013, 20(5):R257-R267.
  • 3Callegari E, Elamin BK, Sabbioni S, et al. Role of microR- NAs in hepatocellular carcinoma: a clinical perspective[J].Onco Targets Ther, 2013, 6:1167-1178.
  • 4Livak KJ, Schmittgen TD. Analysis of relative gene expres- sion data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4):402-408.
  • 5Page AJ, Cosgrove DC, Philosophe B, et al. Hepatocellular carcinoma diagnosis, management, and prognosis[J]. Surg Oncol Clin N Am, 2014, 23(2):289-311.
  • 6Jirun P, Zhang G, Kim HK, et al. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in pa- tients with chronic hepatitis, liver cirrhosis and hepatocel- lular carcinoma[J]. Dis Markers, 2011, 30(6):307-315.
  • 7Qi J, Wang J, Katayama H, et al. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma[J]. Neoplasma, 2012, 60(2):135-142.
  • 8Liu AM, Yao TJ, Wang W, et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study [J]. BMJ Open, 2012, 2(2):e000825.
  • 9Lumayag S, Haldin CE, Corbett NJ, et al. Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration[J]. Proc Natl Acad Sci U S A, 2013, 110(6):E507-E516.
  • 10Tang H, Bian Y, Tu C, et al. The miR-183/96/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas[J]. Curt Cancer Drug Targets, 2013, 13(2):221-231.

同被引文献2

引证文献1

;
使用帮助 返回顶部